Purification of your small molecules by HPLC, from laboratory to industrial scale

Reach Separations and Minakem have decided to establish a collaboration to offer the full range of service to purify your molecules by HPLC to their customers to reduce time-to-market.

Reach Separations aims to accelerate the discovery programs of its customers by identifying the most appropriate separation technology (HPLC and SFC) to purify quickly (chemical or chiral) the potential lead molecules. The laboratories are based in Nottingham, UK and in Strasbourg, France.

If HPLC is the technology of choice for the lead molecule, Minakem will support the process development by offering state-of-the-art HPLC columns of 50, 110, and 300 mm, able to operate in cGMP environment, including for high potent molecules. More than 15 m€ have been invested since 2020 to offer a versatile laboratory, pilot and production workshop.

About Reach
Reach Separations specializes in chromatography for the analysis and purification of small molecules. The latest HPLC and SFC technologies are used side by side to effectively support its clients across the pharmaceutical, agrochemical and fine chemical sectors. As experts in chiral chromatography and impurity isolation Reach Separations have become an essential outsourcing partner for a large and varied client base throughout the UK and Europe.

https://reachseparations.fr/

About Minakem
Minakem (160 m€ sales) specializes in small molecules manufacturing (including highly potent APIs) for CMC activities and at commercial scale. Minakem is also a well-known custom manufacturer of complex, advanced intermediates, including purification by HPLC, under strict cGMP (EMEA, USFDA) conditions for the pharmaceutical industry. All development activities are conducted by highly skilled R&D technical teams supported by strong and state-of-the-art analytical services including solid form and QbD laboratories.

https://minakem.com

 

Véronique LUTUN – Press Relations Minakem
veronique.lutun@minakem.com 

+33 7 50 68 77 80

Stay in touch? Leave us your e-mail address to receive our latest news

Subscribe

News Request